AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2018
Jan 16, 2018
284_dirs_2018-01-16_0ef6521f-c9df-48da-8143-cd031d0b433d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-01-16
Reporting Person: Holston Michael J (EVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-16 | Common Stock | S | 12500.0000 | $61.6300 | Disposed | 49092.2270 | Direct |
Footnotes
F1: The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
F2: Holdings include shares acquired in dividend reinvestment transactions.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8